Search research articles
Contact Us
Filters
Showing results (71-80 of 103) with videos related to
Page
of 11
Sort By:
Cancer Investigation
|
December 5, 2025
Long-Term Oncological Outcomes for Locally Advanced Rectal Cancer Patients with Pathological Complete Response After Neoadjuvant Chemoradiotherapy: A Turkish Oncology Group Study
Mukremin Uysal, Sezer Saglam, İsmail Beypınar, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
April 13, 2024
Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC
Mahmut Emre Yildirim, Nuri Karadurmuş, İlker Nihat Ökten, et al.
Journal of Chemotherapy (Florence, Italy)
|
June 21, 2024
Real-world data on the efficacy and safety of trastuzumab emtansine in patients with metastatic breast cancer previously treated with pertuzumab: Turkish oncology group multicenter study
Özgecan Dülgar, Sema Türker, Gül Başaran, et al.
Neoplasma
|
January 9, 2023
Real-life experience of patients with sarcomatoid renal cell carcinoma: a multicenter retrospective study
Elvina Almuradova, Tugba Basoglu, Erdinc Nayir, et al.
Current Oncology (Toronto, Ont.)
|
November 26, 2025
Efficacy of Anti-VEGF and Anti-EGFRs in Microsatellite Instable (MSI-H) Metastatic Colorectal Cancer in a Turkish Oncology Group (TOG) Cohort Study
İlknur Deliktaş Onur, Mutlu Doğan, Mehmet Akif Öztürk, et al.
BMC Cancer
|
February 14, 2026
Evaluation of the efficacy and tolerability of bevacizumab-based treatments in recurrent primary brain tumors: a multicenter real-world Turkish Oncology Group (TOG) study
Zehra Sucuoğlu İşleyen, Şaban Seçmeler, Abdullah Sakin, et al.
Clinical Genitourinary Cancer
|
April 16, 2024
Adrenocortical Cancer in the Real World: A Comprehensive Analysis of Clinical Features and Management from the Turkish Oncology Group (TOG)
Hatime Arzu Yasar, Burak Yasin Aktas, Gokhan Ucar, et al.
Journal of Geriatric Oncology
|
September 8, 2023
PROPSEA, safety evaluation of palbociclib and ribociclib in older patients with breast cancer: A prospective real-world TOG study
Okan Avcı, Yakup İriağaç, Eyyüp Çavdar, et al.
BMC Cancer
|
January 3, 2024
Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer
Elif Şenocak Taşçı, Başak Oyan, Özlem Sönmez, et al.
BMC Cancer
|
January 23, 2024
Correction: Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer
Elif Şenocak Taşçı, Başak Oyan, Özlem Sönmez, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 103) with videos related to
Sort By:
Page
of 11
Cancer Investigation
|
December 5, 2025
Long-Term Oncological Outcomes for Locally Advanced Rectal Cancer Patients with Pathological Complete Response After Neoadjuvant Chemoradiotherapy: A Turkish Oncology Group Study
Mukremin Uysal, Sezer Saglam, İsmail Beypınar, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
April 13, 2024
Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC
Mahmut Emre Yildirim, Nuri Karadurmuş, İlker Nihat Ökten, et al.
Journal of Chemotherapy (Florence, Italy)
|
June 21, 2024
Real-world data on the efficacy and safety of trastuzumab emtansine in patients with metastatic breast cancer previously treated with pertuzumab: Turkish oncology group multicenter study
Özgecan Dülgar, Sema Türker, Gül Başaran, et al.
Neoplasma
|
January 9, 2023
Real-life experience of patients with sarcomatoid renal cell carcinoma: a multicenter retrospective study
Elvina Almuradova, Tugba Basoglu, Erdinc Nayir, et al.
Current Oncology (Toronto, Ont.)
|
November 26, 2025
Efficacy of Anti-VEGF and Anti-EGFRs in Microsatellite Instable (MSI-H) Metastatic Colorectal Cancer in a Turkish Oncology Group (TOG) Cohort Study
İlknur Deliktaş Onur, Mutlu Doğan, Mehmet Akif Öztürk, et al.
BMC Cancer
|
February 14, 2026
Evaluation of the efficacy and tolerability of bevacizumab-based treatments in recurrent primary brain tumors: a multicenter real-world Turkish Oncology Group (TOG) study
Zehra Sucuoğlu İşleyen, Şaban Seçmeler, Abdullah Sakin, et al.
Clinical Genitourinary Cancer
|
April 16, 2024
Adrenocortical Cancer in the Real World: A Comprehensive Analysis of Clinical Features and Management from the Turkish Oncology Group (TOG)
Hatime Arzu Yasar, Burak Yasin Aktas, Gokhan Ucar, et al.
Journal of Geriatric Oncology
|
September 8, 2023
PROPSEA, safety evaluation of palbociclib and ribociclib in older patients with breast cancer: A prospective real-world TOG study
Okan Avcı, Yakup İriağaç, Eyyüp Çavdar, et al.
BMC Cancer
|
January 3, 2024
Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer
Elif Şenocak Taşçı, Başak Oyan, Özlem Sönmez, et al.
BMC Cancer
|
January 23, 2024
Correction: Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer
Elif Şenocak Taşçı, Başak Oyan, Özlem Sönmez, et al.
Page
of 11